- 6.0%of US adults reported a current ADHD diagnosis in 2023, about 15.5 million peopleCDC MMWR, October 2024
- 55.9%of adults with a current diagnosis were diagnosed at age 18 or olderCDC MMWR, October 2024
- 71.5%of adults with ADHD who took a stimulant for it in the past 12 months had trouble filling a prescription because it was unavailableCDC MMWR, October 2024
- 38.8 vs 19.2psychiatrists per 100,000 residents in New York State and in New JerseyNPPES, November 2026; Census, July 1, 2025
- 203 and 44federal mental health shortage designations in New York and in New JerseyHRSA file downloaded November 15, 2026
- 5ADHD medication products on the FDA shortage list as of November 13, 2026FDA Drug Shortages database
Adults with a current ADHD diagnosis (444 respondents)
Adults with ADHD who took a stimulant for it in the past 12 months (152 respondents)
Source: CDC MMWR 73(40), October 10, 2024, NCHS Rapid Surveys System, October to November 2023 (7,046 interviews). Weighted percentages; diagnosis is self-reported.
| Statistic | Figure | Period | Source |
|---|---|---|---|
| United States | |||
| Adults with a current ADHD diagnosis | 6.0% (about 15.5 million) | October to November 2023 | CDC MMWR 73(40), 2024 |
| Of adults with current ADHD: diagnosed at age 18 or older | 55.9% | October to November 2023 | CDC MMWR 73(40), 2024 |
| Of adults with current ADHD: prescribed ADHD medication in the past 12 months | 50.4% | October to November 2023 | CDC MMWR 73(40), 2024 |
| Of adults with current ADHD: receiving no treatment | 36.5% | October to November 2023 | CDC MMWR 73(40), 2024 |
| Of adults with current ADHD: ever used telehealth for ADHD | 46.0% | October to November 2023 | CDC MMWR 73(40), 2024 |
| Of adults with ADHD who took a stimulant for it in the past 12 months: trouble filling a prescription because it was unavailable | 71.5% | Past 12 months, asked in 2023 | CDC MMWR 73(40), 2024 |
| CDC survey: completed interviews | 7,046 | October to November 2023 | CDC MMWR 73(40), 2024 |
| CDC survey: respondents with a current ADHD diagnosis | 444 | October to November 2023 | CDC MMWR 73(40), 2024 |
| CDC survey: respondents who took a stimulant for ADHD in the past 12 months | 152 | October to November 2023 | CDC MMWR 73(40), 2024 |
| Adults 18 to 44 meeting ADHD criteria on clinician assessment | 4.4% | Interviews 2001 to 2003 | Kessler et al., Am J Psychiatry, 2006 |
| Psychiatrists per 100,000 residents | 19.9 | November 2026 | Our psychiatrists study (NPPES, Census) |
| ADHD medication products on the FDA shortage list | 5 | November 13, 2026 | Our shortage tracker (FDA) |
| FDA package listings for those products marked unavailable | 25 of 219 | November 13, 2026 | Our shortage tracker (FDA) |
| Worldwide | |||
| Persistent adult ADHD (onset in childhood) | 2.58% | Adjusted to the 2020 world population | Song et al., J Glob Health, 2021 |
| Symptomatic adult ADHD (regardless of onset) | 6.76% | Adjusted to the 2020 world population | Song et al., J Glob Health, 2021 |
| New York | |||
| Psychiatrists per 100,000 residents, New York State | 38.8 | November 2026 | Our psychiatrists study (NPPES, Census) |
| Psychiatrists per 100,000 residents, Manhattan | 184.8 | November 2026 | Our psychiatrists study (NPPES, Census) |
| Psychiatrists per 100,000 residents, Brooklyn, Queens, the Bronx and Staten Island combined | 25.5 | November 2026 | Our psychiatrists study (NPPES, Census) |
| Federal mental health shortage designations in New York | 203 | HRSA file downloaded November 15, 2026 | HRSA, mental health HPSA file |
| Mental health shortage designations in New York marked Proposed For Withdrawal (not counted above) | 15 | HRSA file downloaded November 15, 2026 | HRSA, mental health HPSA file |
| Full-time psychiatrists needed to remove New York's designations | about 243 | HRSA file downloaded November 15, 2026 | HRSA, mental health HPSA file |
| Medicare Part D ADHD-medication claims for patients 65+, New York prescribers, change 2019 to 2024 | +50.7% | 2019 to 2024 | Our Medicare study (CMS Part D) |
| New Jersey | |||
| Psychiatrists per 100,000 residents, New Jersey | 19.2 | November 2026 | Our psychiatrists study (NPPES, Census) |
| Highest and lowest county rates: Mercer County and Gloucester County | 41.6 and 3.5 | November 2026 | Our psychiatrists study (NPPES, Census) |
| Psychiatric nurse practitioners per 100,000 residents, New Jersey | 20.2 | November 2026 | Our psychiatrists study (NPPES, Census) |
| Federal mental health shortage designations in New Jersey | 44 | HRSA file downloaded November 15, 2026 | HRSA, mental health HPSA file |
| Full-time psychiatrists needed to remove New Jersey's designations | about 43 | HRSA file downloaded November 15, 2026 | HRSA, mental health HPSA file |
| Medicare Part D ADHD-medication claims for patients 65+, New Jersey prescribers, change 2019 to 2024 | +53.9% | 2019 to 2024 | Our Medicare study (CMS Part D) |
The CSV adds each figure's source URL and the table, field or filter it comes from.
How common is adult ADHD?
The most recent federal estimate is from the CDC's National Center for Health Statistics, which surveyed adults in October and November 2023 and published the results on October 10, 2024. 6.0% of US adults, about 15.5 million people, reported a current ADHD diagnosis. Diagnosis was self-reported, and the survey completed 7,046 interviews, 444 of them with adults who had current ADHD.
Other figures measure different things. The National Comorbidity Survey Replication, published in 2006, estimated that 4.4% of adults aged 18 to 44 met ADHD criteria on a clinician assessment, from interviews in 2001 to 2003. A 2021 global meta-analysis put persistent adult ADHD with childhood onset at 2.58% and symptomatic adult ADHD regardless of onset at 6.76%. Setting these side by side does not show that ADHD has become more common: the definitions, ages and methods differ.
No measured New York or New Jersey rate
The CDC report gives national estimates only, with no figure for any state, and we found no state or city health department survey that measures adult ADHD in New York or New Jersey. A page that states a precise adult ADHD rate for New York, New York City or New Jersey is most likely applying a national number. If either state matched the national rate, about 6 in 100 adults would report a current diagnosis; whether they do has not been measured.
What can be counted locally: clinicians, shortage areas, prescriptions and supply
Psychiatrists. New York State has 38.8 psychiatrists per 100,000 residents in the November 2026 federal NPI file, New Jersey 19.2 and the US 19.9. Manhattan has 184.8; the other four boroughs combined have 25.5. New Jersey's county rates run from 41.6 in Mercer County to 3.5 in Gloucester County. See psychiatrists per 100,000 residents in New York City and New Jersey. A June 2026 data brief from the WWAMI Rural Health Research Center at the University of Washington, cited in our New Jersey statistics article, used NPI records from January 2025 with its own taxonomy filters and counting rules, so its New Jersey figures are not directly comparable with these.
Shortage designations. HRSA's file lists 203 designated mental health shortage areas in New York and 44 in New Jersey; most are for a clinic, prison or hospital rather than a whole area. New York has 15 more designations marked "Proposed For Withdrawal", which are not counted. By HRSA's estimate, about 243 more full-time psychiatrists would be needed to remove New York's designations, and about 43 for New Jersey's.
Medicare prescriptions. Part D claims for ADHD medications for patients 65 and older rose 50.7% for New York prescribers and 53.9% for New Jersey prescribers from 2019 to 2024. See ADHD medication prescriptions in Medicare.
Medication supply. As of November 13, 2026, the FDA listed 5 ADHD medication products as in shortage, with 25 of 219 package listings marked unavailable. See the ADHD medication shortage tracker.
How we counted
National survey. CDC MMWR 73(40), October 10, 2024 (Staley et al.), read from its full text in Europe PMC (PMC11466376) because cdc.gov does not serve scripted downloads. Figures are the report's weighted percentages.
Other prevalence estimates. From the published abstracts of Kessler et al. (2006, PubMed 16585449) and Song et al. (2021, PubMed 33692893).
Shortage designations. HRSA mental health HPSA detail file, HRSA file downloaded November 15, 2026: one record per HPSA ID with status Designated and primary state New York or New Jersey; "psychiatrists needed" is the sum of the HPSA Shortage field, rounded.
Psychiatrists, Medicare and shortages. Taken from our three studies, each built from the federal files named on its page and re-checked against a second source. Their methods and limits apply here.
Limits
- The CDC survey is a single, self-reported snapshot from online panels; it shows no trend and no state figures.
- Clinician counts show where clinicians are registered, not who treats adult ADHD, takes new patients or accepts a given plan.
- Shortage designations can overlap and follow applications by each state, so counts are not a direct measure of need.
- Medicare data cover Medicare Part D only and record prescriptions, not diagnoses.
Sources
- CDC MMWR: ADHD Diagnosis, Treatment, and Telehealth Use in Adults, NCHS Rapid Surveys System, United States, October-November 2023. Published October 10, 2024.
- Kessler et al., The prevalence and correlates of adult ADHD in the United States (Am J Psychiatry). April 2006.
- Song et al., The prevalence of adult ADHD: a global systematic review and meta-analysis (J Glob Health). February 2021.
- HRSA, Mental health HPSA detail file (BCD_HPSA_FCT_DET_MH). HRSA file downloaded November 15, 2026.
- CMS, NPPES NPI file. November 2026.
- CMS, Medicare Part D Prescribers by Geography and Drug. Data years 2019 to 2024.
- FDA, Drug Shortages database. November 13, 2026.
Cite this page
Dr. John C. Shershow, M.D.. (2026). Adult ADHD statistics: national figures and New York and New Jersey data. https://drjohnshershow.com/research/adult-adhd-statistics/
The table behind this page is free to reuse under CC BY 4.0: credit Dr. John C. Shershow, M.D. and link to this page. Download the CSV.